Specific Drug Delivery to Cancer Cells With Double-Imprinted Nanoparticles Against Epidermal Growth Factor Receptor

doi 10.1021/acs.nanolett.7b03206.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Transactivation of Epidermal Growth Factor Receptor Through Platelet-Activating Factor/Receptor in Ovarian Cancer Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2014English

Microtubule Inhibition Causes Epidermal Growth Factor Receptor Inactivation in Oesophageal Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2012English

Site-Specific Androgen Receptor Serine Phosphorylation Linked to Epidermal Growth Factor-Dependent Growth of Castration-Recurrent Prostate Cancer

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

Treatment of Pancreatic Cancer With Epidermal Growth Factor Receptor-Targeted Therapy

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Role of Epidermal Growth Factor Receptor in Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Epidermal Growth Factor Receptor (EGFR) in Biliary Tract Cancer

HPB
HepatologyGastroenterology
2016English

Epidermal Growth Factor Receptor Structural Alterations in Gastric Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2008English

E7080 Suppresses Hematogenous Multiple Organ Metastases of Lung Cancer Cells With Nonmutated Epidermal Growth Factor Receptor

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

Improving Therapy for Patients With Epidermal Growth Factor Receptor-Mutant Lung Cancer

Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy